Trent Abraham

Trent Abraham is a versatile bioanalytical chemist with extensive experience in ADME/DMPK and drug disposition. They have contributed to quantitative and qualitative method development, and small molecule metabolite structure identification across various biological matrices. Trent's background includes roles at Eli Lilly and Company, where they served as an Associate Senior Analytical Chemist and later as a Consultant Bioanalytical Chemist, providing critical oversight and analytical support for clinical and preclinical studies. They are skilled in method development, regulatory documentation, and the coordination of complex bioanalytical projects.